BUROSUMAB
burosumab 30 mg/mL injection, 1 mL vial
BUROSUMAB (15480R)
15480R
Manner of administration:Injection
Restriction
Indication: Tumour-induced osteomalacia
Treatment phase: Initial treatment - New patient
Restriction
Indication: Tumour-induced osteomalacia
Treatment phase: Continuing treatment
Restriction
Indication: Tumour-induced osteomalacia
Treatment phase: Grandfather arrangements - Transitioning from non-PBS to PBS-subsidised supply
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $11,997.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Crysvita | |||||